Literature DB >> 12217792

Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models.

Robert Hoffman1.   

Abstract

We have developed a way of imaging metastases in mice by use of tumour cells expressing green fluorescent protein (GFP) that can be used to examine fresh tissue, both in situ and externally. These mice present many new possibilities for research including real-time studies of tumour progression, metastasis, and drug-response evaluations. We have now also introduced the GFP gene, cloned from bioluminescent organisms, into a series of human and rodent cancer-cell lines in vitro, which stably express GFP after transplantation to rodents with metastatic cancer. Techniques were also developed for transduction of tumours by GFP in vivo. With this fluorescent tool, single cells from tumours and metastases can be imaged. GFP-expressing tumours of the colon, prostate, breast, brain, liver, lymph nodes, lung, pancreas, bone, and other organs have also been visualised externally by use of quantitative transcutaneous whole-body fluorescence imaging. GFP technology has also been used for real-time imaging and quantification of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217792     DOI: 10.1016/s1470-2045(02)00848-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  48 in total

1.  Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis.

Authors:  Yang Xu; Hui-Chuan Sun; Bo Tian; Yan Li; Jie Chen; Jun Chen; Dong-Mei Gao; Qiong Xue; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

2.  Confocal fluorescence microscope with dual-axis architecture and biaxial postobjective scanning.

Authors:  Thomas D Wang; Christopher H Contag; Michael J Mandella; Ning Y Chan; Gordon S Kino
Journal:  J Biomed Opt       Date:  2004 Jul-Aug       Impact factor: 3.170

Review 3.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

4.  Volumetric tomography of fluorescent proteins through small animals in vivo.

Authors:  Giannis Zacharakis; Hirokazu Kambara; Helen Shih; Jorge Ripoll; Jan Grimm; Yoshinaga Saeki; Ralph Weissleder; Vasilis Ntziachristos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

5.  LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.

Authors:  Rene Hennig; Jacinthe Ventura; Ralf Segersvard; Erin Ward; Xian-Zhong Ding; Sambasiva M Rao; Borko D Jovanovic; Takeshi Iwamura; Mark S Talamonti; Richard H Bell; Thomas E Adrian
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 6.  Optical clearing of unsectioned specimens for three-dimensional imaging via optical transmission and emission tomography.

Authors:  Mark Oldham; Harshad Sakhalkar; Tim Oliver; G Allan Johnson; Mark Dewhirst
Journal:  J Biomed Opt       Date:  2008 Mar-Apr       Impact factor: 3.170

Review 7.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

8.  New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice.

Authors:  Akihiro Ito; Yuichi Ito; Shigeru Matsushima; Daisuke Tsuchida; Mai Ogasawara; Junichi Hasegawa; Kazunari Misawa; Eisaku Kondo; Norio Kaneda; Hayao Nakanishi
Journal:  Gastric Cancer       Date:  2013-11-28       Impact factor: 7.370

9.  Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

Authors:  Peter Jantscheff; Vittorio Ziroli; Norbert Esser; Ralph Graeser; Jessica Kluth; Alena Sukolinskaya; Lenka A Taylor; Clemens Unger; Ulrich Massing
Journal:  Clin Exp Metastasis       Date:  2009-09-26       Impact factor: 5.150

10.  A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo.

Authors:  Jian-Xin Yu; Vikram D Kodibagkar; Li Liu; Ralph P Mason
Journal:  NMR Biomed       Date:  2008-08       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.